<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Towards Optimal Valve Prescription for Transcatheter Aortic Valve Replacement (TAVR) Surgery: A Machine Learning Approach - Health AI Hub</title>
    <meta name="description" content="This paper proposes a machine learning approach to optimize transcatheter heart valve (THV) selection for Transcatheter Aortic Valve Replacement (TAVR) surgery.">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Towards Optimal Valve Prescription for Transcatheter Aortic Valve Replacement (TAVR) Surgery: A Machine Learning Approach</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.09198v1" target="_blank">2512.09198v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-09
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Phevos Paschalidis, Vasiliki Stoumpou, Lisa Everest, Yu Ma, Talhat Azemi, Jawad Haider, Steven Zweibel, Eleftherios M. Protopapas, Jeff Mather, Maciej Tysarowski, George E. Sarris, Robert C. Hagberg, Howard L. Haronian, Dimitris Bertsimas
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.09198v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.09198v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper proposes a machine learning approach to optimize transcatheter heart valve (THV) selection for Transcatheter Aortic Valve Replacement (TAVR) surgery. The primary objective is to minimize the risk of permanent pacemaker implantation (PPI), a common postoperative complication. The developed prescriptive model, utilizing a novel integrated dataset from U.S. and Greek populations, demonstrates significant reductions in PPI rates compared to the current standard of care.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly relevant to improving TAVR outcomes, a procedure critical for patients with severe aortic stenosis. By minimizing permanent pacemaker implantation (PPI) risk, it directly addresses a major source of patient morbidity, resource utilization, and healthcare costs, ultimately leading to safer and more effective individualized patient care.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application is a machine learning-driven clinical support tool that provides a personalized prescription strategy for selecting the optimal transcatheter heart valve (THV) type during TAVR surgery. Its objective is to minimize the risk of permanent pacemaker implantation (PPI), thereby improving patient safety and outcomes in cardiovascular care.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical clinical challenge of optimal transcatheter heart valve (THV) selection in TAVR surgery.</li>
                    
                    <li>The primary goal is to minimize the incidence of permanent pacemaker implantation (PPI), a prevalent and costly postoperative complication in TAVR patients.</li>
                    
                    <li>Introduces a data-driven machine learning-based clinical support tool for personalized THV prescription.</li>
                    
                    <li>Constructs a novel, harmonized dataset by integrating patient demographics, computed tomography (CT) scans, and echocardiograms from both U.S. and Greek patient populations, overcoming inter-country data system differences.</li>
                    
                    <li>Employs a specialized "leaf-level analysis" methodology to leverage population heterogeneity and avoid benchmarking against uncertain counterfactual risk estimates.</li>
                    
                    <li>The prescriptive model achieved a 26% reduction in PPI rates compared to standard of care in an internal U.S. patient cohort.</li>
                    
                    <li>Validated externally, the model demonstrated a 16% reduction in PPI rates in a Greek validation cohort, highlighting its generalizability.</li>
                    
                    <li>This work is presented as the first unified and personalized strategy for THV selection in TAVR, leveraging comprehensive patient data and machine learning.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The methodology involves synthesizing a novel, harmonized dataset from U.S. and Greek patient populations, integrating diverse data sources including patient demographics, computed tomography (CT) scans, and echocardiograms, while also harmonizing differences in each country's record systems. A machine learning-based prescriptive model is then developed, utilizing a novel "leaf-level analysis" to exploit population heterogeneity and avoid reliance on uncertain counterfactual risk estimates, with the objective of identifying optimal valve types to minimize PPI risk.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The prescriptive model successfully reduced permanent pacemaker implantation (PPI) rates by 26% compared with the current standard of care in an internal U.S. patient population. Furthermore, an external validation in a Greek cohort demonstrated a 16% reduction in PPI rates. The authors assert this to be the first unified, personalized strategy for transcatheter heart valve (THV) selection in TAVR.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research has the potential to significantly enhance clinical decision-making for TAVR, providing a personalized, data-driven tool for optimal THV selection. Its adoption could lead to a substantial reduction in permanent pacemaker implantations, improving patient safety, reducing long-term complications, and lowering healthcare expenditures associated with secondary procedures and prolonged hospital stays. It could pave the way for more precise and individualized treatment strategies in interventional cardiology.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state specific limitations or caveats of the study.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention future research directions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Cardiology</span>
                    
                    <span class="tag">Interventional Cardiology</span>
                    
                    <span class="tag">Cardiovascular Surgery</span>
                    
                    <span class="tag">Medical Imaging</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Transcatheter Aortic Valve Replacement (TAVR)</span>
                    
                    <span class="tag tag-keyword">Transcatheter Heart Valves (THV)</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">Permanent Pacemaker Implantation (PPI)</span>
                    
                    <span class="tag tag-keyword">Aortic Stenosis</span>
                    
                    <span class="tag tag-keyword">Personalized Medicine</span>
                    
                    <span class="tag tag-keyword">Clinical Decision Support</span>
                    
                    <span class="tag tag-keyword">Data Integration</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Transcatheter Aortic Valve Replacement (TAVR) has emerged as a minimally invasive treatment option for patients with severe aortic stenosis, a life-threatening cardiovascular condition. Multiple transcatheter heart valves (THV) have been approved for use in TAVR, but current guidelines regarding valve type prescription remain an active topic of debate. We propose a data-driven clinical support tool to identify the optimal valve type with the objective of minimizing the risk of permanent pacemaker implantation (PPI), a predominant postoperative complication. We synthesize a novel dataset that combines U.S. and Greek patient populations and integrates three distinct data sources (patient demographics, computed tomography scans, echocardiograms) while harmonizing differences in each country's record system. We introduce a leaf-level analysis to leverage population heterogeneity and avoid benchmarking against uncertain counterfactual risk estimates. The final prescriptive model shows a reduction in PPI rates of 26% and 16% compared with the current standard of care in our internal U.S. population and external Greek validation cohort, respectively. To the best of our knowledge, this work represents the first unified, personalized prescription strategy for THV selection in TAVR.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>